Household & Personal Products
Compare Stocks
5 / 10Stock Comparison
UG vs IOSP vs KRMD vs LIQT vs CODA
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Medical - Instruments & Supplies
Industrial - Pollution & Treatment Controls
Aerospace & Defense
UG vs IOSP vs KRMD vs LIQT vs CODA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Household & Personal Products | Chemicals - Specialty | Medical - Instruments & Supplies | Industrial - Pollution & Treatment Controls | Aerospace & Defense |
| Market Cap | $32M | $1.91B | $207M | $22M | $134M |
| Revenue (TTM) | $11M | $1.78B | $43M | $17M | $28M |
| Net Income (TTM) | $2M | $117M | $-2M | $-9M | $4M |
| Gross Margin | 47.7% | 27.7% | 60.1% | 4.9% | 66.3% |
| Operating Margin | 21.3% | 8.7% | -5.1% | -50.0% | 17.4% |
| Forward P/E | 15.2x | 15.5x | — | — | 22.5x |
| Total Debt | $0.00 | $90M | $3M | $12M | $395K |
| Cash & Equiv. | $1M | $293M | $9M | — | $29M |
UG vs IOSP vs KRMD vs LIQT vs CODA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| United-Guardian, In… (UG) | 100 | 44.4 | -55.6% |
| Innospec Inc. (IOSP) | 100 | 99.4 | -0.6% |
| KORU Medical System… (KRMD) | 100 | 43.9 | -56.1% |
| LiqTech Internation… (LIQT) | 100 | 4.7 | -95.3% |
| Coda Octopus Group,… (CODA) | 100 | 212.5 | +112.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: UG vs IOSP vs KRMD vs LIQT vs CODA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
UG carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 2 yrs, beta 0.33, yield 8.6%
- Beta 0.33, yield 8.6%, current ratio 7.31x
- Lower P/E (15.2x vs 22.5x)
- 20.0% margin vs LIQT's -53.3%
IOSP ranks third and is worth considering specifically for valuation efficiency.
- PEG 0.48 vs CODA's 5.24
KRMD is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 22.2%, EPS growth 56.1%, 3Y rev CAGR 13.8%
- 11.2% 10Y total return vs CODA's 8.4%
Among these 5 stocks, LIQT doesn't own a clear edge in any measured category.
CODA is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.
- Lower volatility, beta 1.00, Low D/E 0.7%, current ratio 8.86x
- 30.7% revenue growth vs UG's -13.4%
- +78.9% vs IOSP's -14.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 30.7% revenue growth vs UG's -13.4% | |
| Value | Lower P/E (15.2x vs 22.5x) | |
| Quality / Margins | 20.0% margin vs LIQT's -53.3% | |
| Stability / Safety | Beta 0.33 vs KRMD's 1.15 | |
| Dividends | 8.6% yield, 2-year raise streak, vs IOSP's 2.2%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +78.9% vs IOSP's -14.9% | |
| Efficiency (ROA) | 16.3% ROA vs LIQT's -29.5%, ROIC 16.8% vs -31.1% |
UG vs IOSP vs KRMD vs LIQT vs CODA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
UG vs IOSP vs KRMD vs LIQT vs CODA — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
IOSP leads in 1 of 6 categories
UG leads 1 • CODA leads 1 • KRMD leads 0 • LIQT leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — UG and CODA each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
IOSP is the larger business by revenue, generating $1.8B annually — 168.6x UG's $11M. UG is the more profitable business, keeping 20.0% of every revenue dollar as net income compared to LIQT's -53.3%. On growth, LIQT holds the edge at +53.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $11M | $1.8B | $43M | $17M | $28M |
| EBITDAEarnings before interest/tax | $2M | $198M | -$1M | -$6M | $6M |
| Net IncomeAfter-tax profit | $2M | $117M | -$2M | -$9M | $4M |
| Free Cash FlowCash after capex | $2M | $88M | $179,290 | -$7M | $7M |
| Gross MarginGross profit ÷ Revenue | +47.7% | +27.7% | +60.1% | +4.9% | +66.3% |
| Operating MarginEBIT ÷ Revenue | +21.3% | +8.7% | -5.1% | -50.0% | +17.4% |
| Net MarginNet income ÷ Revenue | +20.0% | +6.6% | -5.3% | -53.3% | +14.8% |
| FCF MarginFCF ÷ Revenue | +18.1% | +4.9% | +0.4% | -39.3% | +24.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +19.6% | -2.4% | +22.1% | +53.6% | +28.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +27.3% | +167.7% | +33.3% | +69.4% | +3.0% |
Valuation Metrics
IOSP leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 15.2x trailing earnings, UG trades at a 53% valuation discount to CODA's 32.2x P/E. Adjusting for growth (PEG ratio), IOSP offers better value at 0.51x vs CODA's 7.51x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $32M | $1.9B | $207M | $22M | $134M |
| Enterprise ValueMkt cap + debt − cash | $31M | $1.7B | $201M | $34M | $106M |
| Trailing P/EPrice ÷ TTM EPS | 15.22x | 16.41x | -77.76x | -2.59x | 32.16x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 15.45x | — | — | 22.45x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.51x | — | — | 7.51x |
| EV / EBITDAEnterprise value multiple | 13.14x | 8.29x | — | — | 17.85x |
| Price / SalesMarket cap ÷ Revenue | 3.05x | 1.07x | 5.02x | 1.35x | 5.05x |
| Price / BookPrice ÷ Book value/share | 2.86x | 1.44x | 12.03x | 2.14x | 2.30x |
| Price / FCFMarket cap ÷ FCF | 16.86x | 21.68x | — | — | 22.20x |
Profitability & Efficiency
UG leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
UG delivers a 19.1% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $-70 for LIQT. CODA carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to LIQT's 1.17x. On the Piotroski fundamental quality scale (0–9), CODA scores 7/9 vs LIQT's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +19.1% | +9.0% | -13.6% | -70.0% | +7.2% |
| ROA (TTM)Return on assets | +16.3% | +6.5% | -8.3% | -29.5% | +6.6% |
| ROICReturn on invested capital | +16.8% | +11.2% | -19.5% | -31.1% | +11.2% |
| ROCEReturn on capital employed | +18.9% | +11.0% | -14.9% | — | +8.1% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 5 | 2 | 7 |
| Debt / EquityFinancial leverage | — | 0.07x | 0.21x | 1.17x | 0.01x |
| Net DebtTotal debt minus cash | -$1M | -$203M | -$5M | $12M | -$28M |
| Cash & Equiv.Liquid assets | $1M | $293M | $9M | — | $29M |
| Total DebtShort + long-term debt | $0 | $90M | $3M | $12M | $394,932 |
| Interest CoverageEBIT ÷ Interest expense | — | — | — | -13.46x | — |
Total Returns (Dividends Reinvested)
CODA leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CODA five years ago would be worth $14,969 today (with dividends reinvested), compared to $391 for LIQT. Over the past 12 months, CODA leads with a +78.9% total return vs IOSP's -14.9%. The 3-year compound annual growth rate (CAGR) favors CODA at 10.4% vs LIQT's -11.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +18.3% | +0.5% | -20.9% | +54.9% | +25.1% |
| 1-Year ReturnPast 12 months | -6.0% | -14.9% | +63.2% | +64.8% | +78.9% |
| 3-Year ReturnCumulative with dividends | -15.4% | -17.3% | +13.3% | -31.3% | +34.5% |
| 5-Year ReturnCumulative with dividends | -30.0% | -18.3% | +24.0% | -96.1% | +49.7% |
| 10-Year ReturnCumulative with dividends | -12.1% | +84.4% | +1116.4% | -90.9% | +844.4% |
| CAGR (3Y)Annualised 3-year return | -5.4% | -6.1% | +4.2% | -11.8% | +10.4% |
Risk & Volatility
Evenly matched — UG and IOSP each lead in 1 of 2 comparable metrics.
Risk & Volatility
UG is the less volatile stock with a 0.33 beta — it tends to amplify market swings less than KRMD's 1.15 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IOSP currently trades 80.2% from its 52-week high vs KRMD's 67.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.33x | 0.70x | 1.15x | 0.52x | 1.00x |
| 52-Week HighHighest price in past year | $9.88 | $95.55 | $6.61 | $3.35 | $17.28 |
| 52-Week LowLowest price in past year | $5.58 | $65.58 | $2.63 | $1.30 | $5.98 |
| % of 52W HighCurrent price vs 52-week peak | +70.9% | +80.2% | +67.2% | +68.9% | +68.9% |
| RSI (14)Momentum oscillator 0–100 | 46.2 | 59.1 | 42.9 | 57.0 | 48.6 |
| Avg Volume (50D)Average daily shares traded | 4K | 221K | 138K | 50K | 256K |
Analyst Outlook
Evenly matched — UG and IOSP each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: IOSP as "Hold", KRMD as "Buy", CODA as "Buy". Consensus price targets imply 57.7% upside for KRMD (target: $7) vs 17.6% for CODA (target: $14). For income investors, UG offers the higher dividend yield at 8.60% vs IOSP's 2.21%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | — | Buy |
| Price TargetConsensus 12-month target | — | $115.00 | $7.00 | — | $14.00 |
| # AnalystsCovering analysts | — | 9 | 5 | — | 1 |
| Dividend YieldAnnual dividend ÷ price | +8.6% | +2.2% | — | — | — |
| Dividend StreakConsecutive years of raises | 2 | 12 | 0 | — | 0 |
| Dividend / ShareAnnual DPS | $0.60 | $1.70 | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
IOSP leads in 1 of 6 categories (Valuation Metrics). UG leads in 1 (Profitability & Efficiency). 3 tied.
UG vs IOSP vs KRMD vs LIQT vs CODA: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is UG or IOSP or KRMD or LIQT or CODA a better buy right now?
For growth investors, Coda Octopus Group, Inc.
(CODA) is the stronger pick with 30. 7% revenue growth year-over-year, versus -13. 4% for United-Guardian, Inc. (UG). United-Guardian, Inc. (UG) offers the better valuation at 15. 2x trailing P/E, making it the more compelling value choice. Analysts rate KORU Medical Systems, Inc. (KRMD) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — UG or IOSP or KRMD or LIQT or CODA?
On trailing P/E, United-Guardian, Inc.
(UG) is the cheapest at 15. 2x versus Coda Octopus Group, Inc. at 32. 2x. On forward P/E, Innospec Inc. is actually cheaper at 15. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Innospec Inc. wins at 0. 48x versus Coda Octopus Group, Inc. 's 5. 24x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — UG or IOSP or KRMD or LIQT or CODA?
Over the past 5 years, Coda Octopus Group, Inc.
(CODA) delivered a total return of +49. 7%, compared to -96. 1% for LiqTech International, Inc. (LIQT). Over 10 years, the gap is even starker: KRMD returned +1116% versus LIQT's -90. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — UG or IOSP or KRMD or LIQT or CODA?
By beta (market sensitivity over 5 years), United-Guardian, Inc.
(UG) is the lower-risk stock at 0. 33β versus KORU Medical Systems, Inc. 's 1. 15β — meaning KRMD is approximately 247% more volatile than UG relative to the S&P 500. On balance sheet safety, Coda Octopus Group, Inc. (CODA) carries a lower debt/equity ratio of 1% versus 117% for LiqTech International, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — UG or IOSP or KRMD or LIQT or CODA?
By revenue growth (latest reported year), Coda Octopus Group, Inc.
(CODA) is pulling ahead at 30. 7% versus -13. 4% for United-Guardian, Inc. (UG). On earnings-per-share growth, the picture is similar: Innospec Inc. grew EPS 228. 9% year-over-year, compared to -35. 2% for United-Guardian, Inc.. Over a 3-year CAGR, KRMD leads at 13. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — UG or IOSP or KRMD or LIQT or CODA?
United-Guardian, Inc.
(UG) is the more profitable company, earning 20. 0% net margin versus -51. 7% for LiqTech International, Inc. — meaning it keeps 20. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UG leads at 21. 3% versus -50. 3% for LIQT. At the gross margin level — before operating expenses — CODA leads at 66. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is UG or IOSP or KRMD or LIQT or CODA more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Innospec Inc. (IOSP) is the more undervalued stock at a PEG of 0. 48x versus Coda Octopus Group, Inc. 's 5. 24x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Innospec Inc. (IOSP) trades at 15. 5x forward P/E versus 22. 5x for Coda Octopus Group, Inc. — 7. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KRMD: 57. 7% to $7. 00.
08Which pays a better dividend — UG or IOSP or KRMD or LIQT or CODA?
In this comparison, UG (8.
6% yield), IOSP (2. 2% yield) pay a dividend. KRMD, LIQT, CODA do not pay a meaningful dividend and should not be held primarily for income.
09Is UG or IOSP or KRMD or LIQT or CODA better for a retirement portfolio?
For long-horizon retirement investors, United-Guardian, Inc.
(UG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 33), 8. 6% yield). Both have compounded well over 10 years (UG: -12. 1%, LIQT: -90. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between UG and IOSP and KRMD and LIQT and CODA?
These companies operate in different sectors (UG (Consumer Defensive) and IOSP (Basic Materials) and KRMD (Healthcare) and LIQT (Industrials) and CODA (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: UG is a small-cap deep-value stock; IOSP is a small-cap deep-value stock; KRMD is a small-cap high-growth stock; LIQT is a small-cap quality compounder stock; CODA is a small-cap high-growth stock. UG, IOSP pay a dividend while KRMD, LIQT, CODA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.